53043-14-4 Usage
Description
o-n-Amyl-m-cresol is an organic compound with antiseptic properties, commonly used in the pharmaceutical industry for treating minor infections of the mouth and throat. It is one of the two active ingredients in lozenges such as Gorpils and Strepsils, manufactured by Boots Group or Gepach International.
Uses
Used in Pharmaceutical Industry:
o-n-Amyl-m-cresol is used as an active ingredient in lozenges for treating minor infections of the mouth and throat. Its antiseptic properties help in reducing the severity and duration of such infections, providing relief to the users.
Used in Oral Health Products:
o-n-Amyl-m-cresol is used as an antiseptic in oral health products like mouthwashes and throat lozenges, targeting minor infections and promoting oral hygiene. Its effectiveness in combating bacteria and other microorganisms contributes to maintaining a healthy oral environment.
Used in Throat Lozenges:
o-n-Amyl-m-cresol is used as an active ingredient in throat lozenges, such as Gorpils and Strepsils, for providing relief from sore throats and minor mouth infections. Its antiseptic action helps in reducing inflammation and discomfort associated with these conditions.
Safety Profile
Moderately toxic by ingestion.Combustible liquid when exposed to heat or flame.Dangerous; when heated to decomposition it emitsirritating fumes. Incompatible with oxidizing materials.
Check Digit Verification of cas no
The CAS Registry Mumber 53043-14-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,0,4 and 3 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 53043-14:
(7*5)+(6*3)+(5*0)+(4*4)+(3*3)+(2*1)+(1*4)=84
84 % 10 = 4
So 53043-14-4 is a valid CAS Registry Number.
53043-14-4Relevant articles and documents
EFFICIENT AND COST-EFFECTIVE PROCESS FOR THE MANUFACTURE OF AMYL M-CRESOL
-
Page/Page column 32; 36, (2012/02/15)
There is described a process for the preparation of amyl-m-cresol (AMC) which comprises the steps of; (i) reaction of m-cresol with valeric acid, or a derivative thereof, (to form m- cresol valerate (3-toluoyl valerate)); (ii) rearrangement, optionally in situ, of 3-toluoyl valerate in the presence of an oxoacid, provided that the oxoacid is not a carboxylic acid or nitric acid; and (iii) reduction of valeryl m-cresol (VMC), e.g. using a palladium on charcoal catalyst and hydrogen.